Department of Neuropsychiatry, Faculty of Medicine, Assiut University Hospital, Assiut, Egypt; Neuropsychiatric Department, Faculty of Medicine, Aswan University Hospital, Aswan, Egypt.
Neuropsychiatric Department, Faculty of Medicine, South Valley University, Qena University Hospital, Qena, Egypt.
Mult Scler Relat Disord. 2022 Jul;63:103841. doi: 10.1016/j.msard.2022.103841. Epub 2022 May 2.
Fatigue is the most troublesome symptom in relapsing remitting multiple sclerosis (RRMS). It starts early in the disease course, escalates with disease progression and impacts the patients` quality of life. The aim of this work was to estimate the frequency of fatigue and to evaluate the relationship between severity of fatigue, clinical data, level of disability and volumetric brain atrophy in RRMS.
43 RRMS patients with 40 age- and sex-matched normal volunteers were recruited. Demographic and clinical data were recorded. Each participant was assessed with the Expanded Disability Status Scale (EDSS), Fatigue Severity Scale (FSS), Brief Cognitive Assessment for Multiple Sclerosis (BICAMS) and a variety of brain volumetric measures.
31 (72.1%) of RRMS patients were found to have fatigue. There were no significant differences in demographic data between patients with or without fatigue according to FSS. However, patients with fatigue had a higher number of attacks, and higher scores in the EDSS and BICAMS than non-fatigued patients. There was a greater reduction in total brain volume, cerebral grey matter, and brain stem, thalamic and caudate volumes in fatigued compared with the non-fatigued patients and controls. FSS was significantly correlated with patients' age, duration of illness, total number of attacks, EDSS, and BICAMS. Total brain, cerebral grey matter and thalamic volumes all had negative correlations with fatigue severity. Regression analysis showed that EDSS accounted for 46% of the variance in fatigue scores while thalamic and brainstem atrophy accounted for 50.7%.
Fatigue was fairly common in RRMS patients. Level of disability and atrophy of the thalamus and brain stem were the best predictors of fatigue.
疲劳是复发缓解型多发性硬化症(RRMS)中最麻烦的症状。它在疾病早期就开始出现,随着疾病的进展而加剧,并影响患者的生活质量。本研究旨在评估 RRMS 患者疲劳的发生率,并评估疲劳严重程度与临床数据、残疾程度和脑容积萎缩之间的关系。
共招募了 43 名 RRMS 患者和 40 名年龄和性别匹配的正常志愿者。记录了人口统计学和临床数据。每位参与者均接受扩展残疾状况量表(EDSS)、疲劳严重程度量表(FSS)、多发性硬化症简要认知评估(BICAMS)和各种脑容积测量评估。
31 名(72.1%)RRMS 患者被发现存在疲劳。根据 FSS,疲劳患者和非疲劳患者在人口统计学数据方面无显著差异。然而,疲劳患者的发作次数更多,EDSS 和 BICAMS 评分也高于非疲劳患者。与非疲劳患者和对照组相比,疲劳患者的总脑体积、大脑灰质和脑干、丘脑和尾状核体积均有更大程度的减少。FSS 与患者的年龄、疾病持续时间、总发作次数、EDSS 和 BICAMS 显著相关。总脑体积、大脑灰质和丘脑体积均与疲劳严重程度呈负相关。回归分析显示,EDSS 占疲劳评分方差的 46%,而丘脑和脑干萎缩占 50.7%。
RRMS 患者中疲劳较为常见。残疾程度和丘脑及脑干萎缩是疲劳的最佳预测指标。